Qu Biologics Launches Treatment Trial for Crohn’s Disease
Canadian participants are being sought for a new Health Canada-approved clinical trial for the treatment of Crohn’s disease , the Vancouver-based biopharmaceutical company Qu Biologics announced today.
Read this article:
Qu Biologics Launches Treatment Trial for Crohn’s Disease